Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in TaiwanChi‐Ling Chen, Hwai‐I Yang, Wei‐Shiung Yang et al.|Gastroenterology|2008Cited by 547
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Yi‐Hsiang Huang et al.|Liver International|2016Cited by 221